Salarius Pharmaceuticals (SLRX)
(Delayed Data from NSDQ)
$0.44 USD
+0.03 (6.00%)
Updated Jun 11, 2024 09:48 AM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Salarius Pharmaceuticals, Inc. [SLRX]
Reports for Purchase
Showing records 41 - 44 ( 44 total )
Company: Salarius Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
FDA Fast Track Designation for Seclidemstat a Notable Achievement
Provider: DIAMOND EQUITY RESEARCH LLC
Analyst: DIAMOND H
Company: Salarius Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
FDA Fast Track Designation for Seclidemstat a Notable Achievement
Provider: DIAMOND EQUITY RESEARCH LLC
Analyst: DIAMOND H
Company: Salarius Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
FDA Fast Track Designation for Seclidemstat a Notable Achievement
Provider: DIAMOND EQUITY RESEARCH LLC
Analyst: DIAMOND H
Company: Salarius Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
We are Initiation of Coverage of Salarius Pharmaceuticals, Inc.
Provider: DIAMOND EQUITY RESEARCH LLC
Analyst: DIAMOND H